Author: admin

Acute Ischemic Stroke Market Size was ~USD 1,300 Million in the 7MM in 2022 | DelveInsight

DelveInsight’s “Acute Ischemic Stroke Market Insights, Epidemiology, and Market Forecast — 2032” report delivers an in-depth understanding of the Acute Ischemic Stroke, historical and forecasted epidemiology as well as the Acute Ischemic Stroke market trends in the United States, EU4 (Germany, Spain, Italy, France) and the United Kingdom, and Japan.

 

Key Takeaways from the Acute Ischemic Stroke Market Research Report

  • The increase in Acute Ischemic Stroke Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
  • As per DelveInsight analysis, the Acute Ischemic Stroke market is anticipated to witness growth at a considerable CAGR.
  • As per DelveInsight analysis, in 2022, the total Acute Ischemic Stroke incident cases was around 1,608,975 in the 7MM. These cases are projected to increase during the forecast period (2023-2034).
  • As per DelveInsight’s epidemiology model, acute ischemic stroke is seen more among males than in females in the 7MM. However, in the US, more number of females are affected with AIS than males.
  • The leading Acute Ischemic Stroke Companies working in the market include Acticor Biotech, Meridigen Biotech Co., Prolong Pharmaceuticals, Nanjing Yoko Biomedical Co., Ltd., TrueBinding, Inc., GNT Pharma, Roche, DiaMedica Therapeutics Inc, Athersys, Inc., Tarveda Therapeutics, Lumosa Therapeutics, NC Medical Research Inc, aptaTargets, Bristol-Myers Squibb, NuvOX Pharma, Simcere Pharmaceutical Co., Ltd., Genentech, Inc., NoNO Inc., Pharming Technologies B.V., Biogen, Avilex Pharma, SanBio, ZZ Biotech,, and others.
  • Promising Acute Ischemic Stroke Pipeline Therapies in the various stages of development include UMC119-06, JTR-161, Tirofiban 0.05 MG/ML, 0.9% sodium chloride solution, YM872 (zonampanel), t-PA (alteplase), Elezanumab, Intravenous ACT017 1000 mg, rhPro-UK, rt-PA, and others.
  • April 2024: Penumbra Inc.- The objective of this study is to demonstrate the safety and efficacy of the Penumbra System including Thunderbolt Aspiration Tubing (Thunderbolt) in a population presenting with acute ischemic stroke (AIS) secondary to intracranial large vessel occlusion (LVO) who are eligible for mechanical thrombectomy.
  • April 2024: Shionogi announced a study of Phase 2 clinical trials for Redasemtide. The purpose of this study is to evaluate the efficacy and safety of redasemtide in adult participants with acute ischemic stroke (AIS).

 

Discover which therapies are expected to grab the Acute Ischemic Stroke Market Share @ Acute Ischemic Stroke Market Outlook

 

Acute Ischemic Stroke Overview

An acute ischemic stroke occurs when there is a sudden disruption of blood flow to a specific part of the brain, leading to a lack of oxygen and nutrients to that area. This disruption is typically caused by a blockage in one of the brain’s blood vessels, which can be due to a blood clot or an atherosclerotic plaque (a buildup of fatty deposits in the arteries). As a result, brain cells in the affected area begin to die, leading to a range of neurological symptoms.re.

 

Acute Ischemic Stroke Epidemiology Insights

The epidemiology section of Acute Ischemic Stroke offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.

  • Total Acute Ischemic Stroke Incident Cases
  • Acute Ischemic Stroke Gender-specific Cases
  • Acute Ischemic Stroke Age-specific Cases
  • Acute Ischemic Stroke Type-specific Cases

 

Download the report to understand which factors are driving Acute Ischemic Stroke Epidemiology trends @ Acute Ischemic Stroke Epidemiological Insights

 

Acute Ischemic Stroke Market Insights

Acute Ischemic Stroke focuses on treating the immediate acute phase to reduce the progression of the ischemia, followed simultaneously by an attempt at revascularization and reperfusion of the brain parenchyma. Further treatment includes reducing the damage and neuronal cell death caused by the ischemia and subsequent metabolic cascade brought about by the abrupt reperfusion. Finally, treatment focuses on rehabilitation and retarding the progression of vascular disease as well as the prevention of further strokes.

 

Acute Ischemic Stroke Treatment Market Landscape

  • Alteplase: The AHA/ASA recommends intravenous (IV) alteplase for patients who satisfy inclusion criteria and have symptom onset or last known baseline within 3 h. IV alteplase is 0.9 mg/kg, with a maximum dose of 90 mg. The first 10% of the dose is given over the first minute as a bolus, and the remainder is given over the next 60 min. The time has been extended to 4.5 h for selected candidates. 
  • BRILINTA (ticagrelor): BRILINTA is an oral, reversible, direct-acting P2Y12 receptor antagonist that inhibits platelet activation. In November 2020, the US FDA approved BRILINTA in the US to reduce the risk of stroke in patients with an acute ischemic stroke or high-risk TIA. In patients with AIS or high-risk TIA, treatment with a 180 mg loading dose of BRILINTA and then with 90 mg twice daily for up to 30 days is recommended. 
  • Aspirin is recommended within 24–48 h of symptom onset. High-intensity statins (atorvastatin 80 mg daily or rosuvastatin 20 mg daily) are recommended for patients 75 years old or younger with clinical atherosclerotic cardiovascular disease. In addition, patients may be continued on statins if they were on them before the ischemic stroke. In patients with atrial fibrillation, the guidelines state it is reasonable to initiate oral anticoagulation within 4–14 days after neurological symptoms onset.

 

To know more about Acute Ischemic Stroke treatment guidelines, visit @ Acute Ischemic Stroke Treatment Market Landscape

 

Acute Ischemic Stroke Market Outlook

The report’s outlook on the Acute Ischemic Stroke market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Acute Ischemic Stroke therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Acute Ischemic Stroke drug and late-stage pipeline therapy. It assesses their impact based on various factors such as annual therapy costs, inclusion/exclusion criteria, mechanism of action, compliance rates, market demand, patient population growth, covered patient segments, anticipated launch year, competition with other therapies, brand value, and input from key opinion leaders. The analyzed Acute Ischemic Stroke market data are presented concisely through relevant tables and graphs to offer a clear overview of the market dynamics.

 

Acute Ischemic Stroke Drugs Uptake

 

  • Glenzocimab (ACT017): Acticor Biotech

Glenzocimab (ACT017) is a humanized monoclonal antibody (mAb) fragment directed against a novel target of major interest, platelet glycoprotein VI (GPVI). It inhibits platelet binding to the thrombus without affecting physiological hemostasis, thereby limiting the bleeding risk, particularly in the brain. GPVI is expressed exclusively by platelets and their precursors, megakaryocytes. It is a key receptor on platelets for polymerized fibrin, fibrinogen, and collagen. In July 2022, the EMA granted Priority Medicines (PRIME) status for glenzocimab, for the treatment of patients with stroke. The drug has completed a Phase Ib/IIa (ACTIMIS), and currently is conducting a Phase II/III (ACTISAVE) trial for the efficacy and safety study of glenzocimab (used as an add-on therapy on top of standard of care in the 4.5 hours following an acute ischemic stroke). Result from ACTISAVE study is expected in the second quarter of 2024 and based on this result, company plans to consult the EMA and FDA during 2024 to confirm the Phase III design that will further support registration in both Europe and the US.

 

  • DM199: DiaMedica Therapeutics

DM199 is a recombinant (synthetic) form of human tissue kallikrein-1 (KLK1). KLK1 is a serine protease (protein) that plays an important role in the regulation of diverse physiological processes, including blood flow, inflammation, fibrosis, oxidative stress, and neurogenesis via a molecular mechanism that increases the production of nitric oxide and prostaglandin. In September 2021, the US FDA granted fast track designation to DM199 for treating AIS. In June 2023, the US FDA removed the clinical hold on DM199 Phase II/III trial for ischemic stroke. The drug has completed Phase I and II studies, and undergoing a Phase II/III (ReMEDy2) trial for the treatment of AIS, administered via IV/SC route.

 

  • Milvexian: Bristol Myers Squibb/Janssen Pharmaceutical

Milvexian (BMS‐986177/JNJ‐70033093) is a potential first-in-class oral factor XIa (FXIa) inhibitor (anti-thrombotic) being studied for the prevention and treatment of major thrombotic conditions. Factor XI (FXI) amplifies thrombin generation and has a limited role in hemostasis. Targeted FXI inhibition may  reduce the burden of vascular and thromboembolic diseases while preserving hemostasis. The drug has completed Phase II trial and launched a pivotal Phase III (LIBREXIA-STROKE) clinical trial program that aims to evaluate milvexian in addition to standard of care antiplatelet therapy for stroke prevention in patients after an acute ischemic stroke.

 

Major Acute Ischemic Stroke Companies

Several companies working in the market include Abbott, Orion Corporation, Bristol-Myers Squibb, Colorado Prevention Center, Cardioxyl Pharamaceutical Inc., Novartis Pharmaceuticals, Sanjiu Medical & Pharmaceutical Co., Ltd., Boehringer Ingelheim, Innogene Kalbiotech Pte. Ltd, and others.

 

Learn more about the FDA-approved drugs for Acute Ischemic Stroke @ Drugs for Acute Ischemic Stroke Treatment

 

Scope of the Acute Ischemic Stroke Market Research Report

  • Coverage- 7MM
  • Study Period- 2019-2032
  • Acute Ischemic Stroke Companies- Acticor Biotech, Meridigen Biotech Co., Prolong Pharmaceuticals, Nanjing Yoko Biomedical Co., Ltd., TrueBinding, Inc., GNT Pharma, Roche, DiaMedica Therapeutics Inc, Athersys, Inc., Tarveda Therapeutics, Lumosa Therapeutics, NC Medical Research Inc, aptaTargets, Bristol-Myers Squibb, NuvOX Pharma, Simcere Pharmaceutical Co., Ltd., Genentech, Inc., NoNO Inc., Pharming Technologies B.V., Biogen, Avilex Pharma, SanBio, ZZ Biotech,, and others.
  • Acute Ischemic Stroke Pipeline Therapies- UMC119-06, JTR-161, Tirofiban 0.05 MG/ML, 0.9% sodium chloride solution, YM872 (zonampanel), t-PA (alteplase), Elezanumab, Intravenous ACT017 1000 mg, rhPro-UK, rt-PA, and others.
  • Acute Ischemic Stroke Market Dynamics: Acute Ischemic Stroke Market Drivers and Barriers
  • Acute Ischemic Stroke Market Access and Reimbursement, Unmet Needs, KOL’s Views, and Analyst’s Views

 

Discover more about Acute Ischemic Stroke Drugs in development @ Acute Ischemic Stroke Clinical Trials Assessment

 

Table of Content

1. Key Insights

2. Report Introduction

3. Acute Ischemic Stroke (AIS) Market Overview at a Glance

4. Executive Summary of Acute Ischemic Stroke (AIS)

5. Key Events

6. Epidemiology and Patient Population

7. Disease Background and Overview

8. Epidemiology and Patient Population

9. Patient Journey

10. Marketed Product

11. Acute Ischemic Stroke Emerging Therapies

12. Acute Ischemic Stroke: 7 Major Market Analysis

13. SWOT Analysis

14. KOL Views

15. Unmet Needs

16. Acute Ischemic Stroke Market Access

17. Appendix

18. DelveInsight Capabilities

19. Disclaimer

20. About DelveInsight

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Acute Ischemic Stroke Market Size was ~USD 1,300 Million in the 7MM in 2022 | DelveInsight

Acute Heart Failure Market Size is expected to Grow by 2032 | DelveInsight

DelveInsight’s “Acute heart failure Market Insights, Epidemiology, and Market Forecast — 2032” report delivers an in-depth understanding of the Acute heart failure, historical and forecasted epidemiology as well as the Acute heart failure market trends in the United States, EU4 (Germany, Spain, Italy, France) and the United Kingdom, and Japan.

 

Key Takeaways from the Acute Heart Failure Market Research Report

  • The increase in Acute Heart Failure Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
  • As per DelveInsight analysis, the Acute Heart Failure market is anticipated to witness growth at a considerable CAGR.
  • The leading Acute Heart Failure Companies working in the market include Abbott, Orion Corporation, Bristol-Myers Squibb, Colorado Prevention Center, Cardioxyl Pharamaceutical Inc., Novartis Pharmaceuticals, Sanjiu Medical & Pharmaceutical Co., Ltd., Boehringer Ingelheim, Innogene Kalbiotech Pte. Ltd, and others.
  • Promising Acute Heart Failure Pipeline Therapies in the various stages of development include levosimendan, dobutamine, Serelaxin, Shenfu Zhusheye, and others.
  • April 2024: Procyrion- The study is a prospective, multi-center, randomized, nonblinded study to evaluate the safety and effectiveness of the Aortix System versus standard of care medical therapy in patients hospitalized with acute decompensated heart failure (ADHF) and persistent congestion despite usual medical management.
  • April 2024: Abiomed Inc.- The objective of this early feasibility study is to evaluate the safety and performance of the preCARDIA System for Superior Vena Caval (SVC) intermittent mechanical occlusion as a therapeutic approach in significantly congested subjects with Acute Decompensated Heart Failure (ADHF), who are not diuresing adequately.
  • March 2024: Nephronyx Ltd- The objective of this interventional study is to evaluate the safety and functional performance of the Nephronyx System in patients with ADHF, presenting clinical signs of volume overload and compromised response to diuretics.
  • March 2024: Juntendo University announced a study of Phase 3 clinical trials for Empagliflozin 10 MG. The EMPA-AHF trial is a multicentre, randomized, double-blind, placebo-controlled trial designed to evaluate the efficacy and safety of early initiation of once-daily oral empagliflozin 10 mg in patients hospitalized for patients with acute heart failure (AHF) who are at a high risk of adverse events.
  • March 2024: Vanderbilt University announced a study of Phase 3 clinical trials for Dapagliflozin 10 MG. This is a randomized trial of the addition of dapagliflozin to patients with or without type 2 diabetes hospitalized with acute decompensated heart failure (ADHF). Participants will be recruited following an initial standard evaluation in the ED and randomized within 24 hours of presentation for ADHF in a 1:1 fashion to protocolized diuretic therapy or dapagliflozin + protocolized diuretic therapy.

 

Discover which therapies are expected to grab the Acute Heart Failure Market Share @ Acute Heart Failure Market Outlook

 

Acute Heart Failure Overview

Acute heart failure is a condition in which the heart suddenly becomes unable to pump blood efficiently throughout the body. This inefficiency can lead to a buildup of fluids in the lungs and other parts of the body, such as the legs and the abdominal area. Acute heart failure can occur in people who have never had heart failure before, or it can represent a sudden worsening of symptoms in someone who has chronic heart failure.

 

Acute Heart Failure Epidemiology Insights

The epidemiology section of Acute Heart Failure offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.

 

Download the report to understand which factors are driving Acute Heart Failure Epidemiology trends @ Acute Heart Failure Epidemiological Insights

 

Acute Heart Failure Drugs Market

The Acute Heart Failure Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Acute Heart Failure signaling in Acute Heart Failure are likely to uncover new therapeutic targets and further expand treatment options for patients.

 

Acute Heart Failure Treatment Market Landscape

The Acute Heart Failure treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Acute Heart Failure has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.

 

To know more about Acute Heart Failure treatment guidelines, visit @ Acute Heart Failure Treatment Market Landscape

 

Acute Heart Failure Market Outlook

The report’s outlook on the Acute Heart Failure market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Acute Heart Failure therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Acute Heart Failure drug and late-stage pipeline therapy. It assesses their impact based on various factors such as annual therapy costs, inclusion/exclusion criteria, mechanism of action, compliance rates, market demand, patient population growth, covered patient segments, anticipated launch year, competition with other therapies, brand value, and input from key opinion leaders. The analyzed Acute Heart Failure market data are presented concisely through relevant tables and graphs to offer a clear overview of the market dynamics.

 

Acute Heart Failure Drugs Uptake

The drug chapter of the Acute Heart Failure report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, advantages, disadvantages of each drug, as well as the latest news and press releases related to Acute Heart Failure.

 

Major Acute Heart Failure Companies

Several companies working in the market include Abbott, Orion Corporation, Bristol-Myers Squibb, Colorado Prevention Center, Cardioxyl Pharamaceutical Inc., Novartis Pharmaceuticals, Sanjiu Medical & Pharmaceutical Co., Ltd., Boehringer Ingelheim, Innogene Kalbiotech Pte. Ltd, and others.

 

Learn more about the FDA-approved drugs for Acute Heart Failure @ Drugs for Acute Heart Failure Treatment

 

Scope of the Acute Heart Failure Market Research Report

  • Coverage- 7MM
  • Study Period- 2019-2032
  • Acute Heart Failure Companies- Abbott, Orion Corporation, Bristol-Myers Squibb, Colorado Prevention Center, Cardioxyl Pharamaceutical Inc., Novartis Pharmaceuticals, Sanjiu Medical & Pharmaceutical Co., Ltd., Boehringer Ingelheim, Innogene Kalbiotech Pte. Ltd, and others.
  • Acute Heart Failure Pipeline Therapies- levosimendan, dobutamine, Serelaxin, Shenfu Zhusheye, and others.
  • Acute Heart Failure Market Dynamics: Acute Heart Failure Market Drivers and Barriers
  • Acute Heart Failure Market Access and Reimbursement, Unmet Needs, KOL’s Views, and Analyst’s Views

 

Discover more about Acute Heart Failure Drugs in development @ Acute Heart Failure Clinical Trials Assessment

 

Table of Content

1. Key Insights

2. Executive Summary of Acute Heart failure (AHF)

3. Competitive Intelligence Analysis for Acute Heart failure (AHF)

4. Acute Heart failure (AHF): Market Overview at a Glance

5. Acute Heart failure (AHF): Disease Background and Overview

6. Patient Journey

7. Acute Heart failure (AHF) Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Acute Heart failure (AHF) Unmet Needs

10. Key Endpoints of Acute Heart failure (AHF) Treatment

11. Acute Heart failure (AHF) Marketed Products

12. Acute Heart failure (AHF) Emerging Therapies

13. Acute Heart failure (AHF): Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Acute Heart failure (AHF)

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Acute Heart Failure Market Size is expected to Grow by 2032 | DelveInsight

India Furniture Market Revenues to Reach USD 29.86 billion by 2029 – Market Size, Share, Forecasts, & Trends Analysis Report by Mordor Intelligence

According to the latest research report titled, “India Furniture Market (2024 – 2029)” by Mordor Intelligence, the India Furniture Market is estimated at USD 17.56 billion in 2024 and growing at a CAGR of 11.20% during the forecast period. 

India has garnered global recognition for its distinct and exquisite furniture design, characterized by rich handcraft and captivating traditional artistry. The Indian furniture industry has evolved significantly over the years, transcending from basic chairs and tables to encompass a diverse range of interior furnishings such as wardrobes and sofas. Furniture holds a significant place in Indian households, symbolizing generations of cultural heritage. 

The expansion of the Indian furniture market can be attributed to several factors including the burgeoning middle-class population, increasing disposable incomes, and the rise of urban dwellings. While the market has traditionally been dominated by numerous small, unorganized local firms, organized players have made significant strides in recent years. 

Report Summary 

  • Market Size (2024): USD 17.56 billion 
  • Market Size (2029): USD 29.86 billion 
  • CAGR (2024 – 2029): 11.20% 
  • Study Period: (2020-2029) 
  • Report Scope: Market Dynamics, Revenue Forecast & Segmentation, Competitive Landscape & Recent Developments, Market Growth, Future Opportunities, and Trends    

Which are the Top Companies in the India Furniture Market?     

The Indian furniture market is fiercely competitive and fragmented, with a handful of major players such as Godrej, Zuari, Durian, Nilkamal, and Featherlite dominating the organized sector. Despite this, the market is ripe for new entrants due to relatively low barriers to entry. 

Prominent players in the India Furniture Market: 

  • Godrej Interio 
  • Zuari Furniture 
  • Durian 
  • Usha Lexus Furniture 
  • Damro 
  • Evok 
  • Ikea 
  • Hulsta 
  • Wipro Furniture 
  • Nilkamal Furniture 
  • Other Prominent Companies (Dynasty, Featherlite, Omfurn India Ltd, Pepperfry, and Urban Ladder, etc)* 

Other Reports that Might be of Your Interest 

  • Textile Home Decor Market Report: The Textile Home Decor Market size is estimated at USD 89.20 billion in 2024, and is expected to reach USD 109.21 billion by 2029, growing at a CAGR of 4.13% during the forecast period (2024-2029) 
  • Furniture Market Report: The Furniture Market size is estimated at USD 637.5 billion in 2024, and is expected to reach USD 823.75 billion by 2029, growing at a CAGR of 5.25% during the forecast period (2024-2029) 

Key Highlights from the India Furniture Market Report 

 

1. Residential Real Estate Sector Growth Fuels Market Expansion 

  • The expansion of the Indian economy has also boosted the demand for real estate and commercial buildings in the country. 
  • While residential building accounts for most of the real estate in India, commercial construction has increased to meet the growing need for office space.  
  • Because of the growing population and desire for cheap housing, the Indian residential real estate industry has been experiencing expansion.  
  • In recent years, major metropolitan areas, such as Delhi, Mumbai, and Kolkata, have seen an increase in demand for luxury housing complexes, such as villas, penthouses, and apartments. 
  • This has increased demand for furniture, such as sofa sets, dining sets, beds, and chairs, which is expected to continue to rise in future years. 
  • The home decor sector has benefited from the rise of the residential real estate industry over the previous few decades. 
  • The rise of this area is being driven by increased awareness among homeowners for fashionable interiors and beautiful indoors. 

2. Tourism and Hospitality Industry Propel Market Growth 

In the past decade, the Indian tourism industry has experienced significant and consistent growth. However, in 2020, due to COVID-19 travel restrictions, international visitor numbers plummeted by 75% to less than 3 million. In 2019, India welcomed 28.9 million tourists, including non-resident Indians, contributing to various sectors. Consequently, there is a surge in demand for hotel accommodations, driving the need for substantial hotel room expansions. This increased demand also extends to the furniture industry, particularly for hotel furniture. Projections by the Indian government indicate a potential market of 1.2 million cruise travelers by 2030-31, prompting investments such as the Dream Hotel Group’s plan to allocate approximately USD 300 million towards the Indian cruise industry’s development within the next 3-5 years. 

What are the Latest Developments in the India Furniture Market?    

  • In November 2023: Sheela Foam’s acquisition of Kurlon aims to consolidate the fragmented market of mattresses and foam-based products. This strategic move will also diversify Sheela Foam’s customer base, particularly into the Southern and Eastern regions of India.  
  • In March 2024: Ashley acquired Resident, a major furniture and bedding brand, along with its accessory brands such as Awara, DreamCloud, Nectar, and Siena, bringing them under new ownership. The acquiring company has a presence online and through physical stores at 1,125 locations across 67 countries. 

Mordor Intelligence Report on the India Furniture Market segments the market based on product type, application, and geography: 

  • By Material  
  • Wood 
  • Metal 
  • Plastic and Other Furniture 
  • By Type 
  • Home Furniture 
  • Office Furniture 
  • Hospitality Furniture 
  • Other Furniture 
  • By Distribution Channel 
  • Supermarkets/Hypermarkets 
  • Specialty Stores 
  • Online 
  • Other Distribution Channels 

In a nutshell, the Mordor Intelligence Market Research Report provides in-depth market insight to industry players, investors, researchers, consultants, and business strategists, looking for comprehensive details on the India Furniture Market. Get a glance at the India Furniture Market Report (2024 – 2029) 

About Mordor Intelligence 

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.  

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.   

Other Related Reports that Might be of Interest 

  • Office Furniture Market Report: The Office Furniture Market size is estimated at USD 65.02 billion in 2024, and is expected to reach USD 88 billion by 2029, growing at a CAGR of 6.24% during the forecast period (2024-2029) 
  • India Home Textile Market Report: The India Home Textile Market size is estimated at USD 9.60 billion in 2024, and is expected to reach USD 15.36 billion by 2029, growing at a CAGR of 9.84% during the forecast period (2024-2029) 

Media Contact
Company Name: Mordor Intelligence Private Limited
Contact Person: Prateeksha Rawat
Email: Send Email
Phone: +1 617-765-2493
Address:5th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli
City: Hyderabad
State: Telangana 500008
Country: India
Website: https://www.mordorintelligence.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: India Furniture Market Revenues to Reach USD 29.86 billion by 2029 – Market Size, Share, Forecasts, & Trends Analysis Report by Mordor Intelligence

Bio-based Pigments and Dyes Market 2024-2031 Exclusive Study Report By Leading Research Firm

“Bio-based Pigments and Dyes Market”
Bio-based Pigments and Dyes Market is valued at US$ 31.8 Bn in 2023, and it is expected to reach US$ 43.9 Bn by 2031, with a CAGR of 4.23% during the forecast period of 2024-2031.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Bio-based Pigments and Dyes Market – (By Production (Microorganisms and Plant Origin Material), By Application (Textiles, Pharmaceuticals, Cosmetics, Pens & Inks, Bio-plastic and Food & Beverage)) Trends, Industry Competition Analysis, Revenue and Forecast To 2031.”

According to the latest research by InsightAce Analytic, the Global Bio-based Pigments and Dyes Market is valued at US$ 31.8 Bn in 2023, and it is expected to reach US$ 43.9 Bn by 2031, with a CAGR of 4.23% during the forecast period of 2024-2031.

Bio-based pigments and dyes describe organic colorants that come from plants. They are derived from plant extracts, fruits, and vegetables, which are renewable resources. Synthetic pigments and dyes are derived from fossil fuels, while bio-based pigments and dyes are more sustainable and longer-lasting. Various products and services, including textiles, printing inks, paints and coatings, and personal care products, rely on them. Dye and pigment products made from biological sources are in high demand in the textile sector. Textiles made with bio-based colorants are more popular because of the increasing interest in natural and environmentally friendly clothing. Governments have been pushing for more funding for infrastructure development projects in response to the growing population and the fast pace of industrialization. Construction spending is on the rise globally, which means there will be a huge demand for products in the years ahead. However, growing global environmental concerns are leading to regulatory shifts that are expected to slow down the market.

 

Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/2342

 

List of Prominent Players in the Bio-based Pigments and Dyes Market:

  • BASF SE
  • Cabot Corporation
  • Clariant
  • Horizon Research Lab
  • Huntsman Corporation
  • Kiri Industries
  • Kronos Worldwide
  • Pili
  • Sea Colors
  • Stony Creek Colors
  • Sudarshan Chemical
  • Treffert
  • Others

 

Market Dynamics:

Drivers-

The growing demand for the bio-based pigments and dyes market is fueled by the inherent qualities and benefits of natural safety. The cosmetics, food, and pharmaceutical industries are the latest to make aggregate claims for bio-based pigments. Demand for environmentally friendly pigments and dyes is rising due to growing environmental consciousness. There will be an increased trend in demand for bio-based products because most consumers like them over synthetic alternatives. Due to the steady rise in these markets, these industries are expected to attract increasing demand in the foreseeable year.

 

Challenges:

The prime challenge is a lack of awareness, a shortage of competent individuals, and a lack of norms and protocol because of lockdowns and isolation in emerging countries, which is predicted to slow the growth of the bio-based pigments and dyes market. Consumers’ ignorance about the advantages of bio-based pigments and dyes and the inadequate infrastructure in some areas limit the market’s expansion. The most significant environmental concerns are water contamination during production, the high metal content of pigments, and the excessive water consumption in the textile sector when rinsing dyes. As a result of the global supply chain disruptions caused by the COVID-19 epidemic, the production and distribution of bio-based pigments and dyes have been impacted. Because of the problems brought about by the restrictions on international trade and transportation, the supply chain has experienced delays and interruptions.

 

Regional Trends:

The North American bio-based pigments and dyes market is anticipated to register a major market share in terms of revenue. It is projected to grow at a high CAGR in the near future because of ongoing tendencies in the food and pharmaceutical industries. Demand from various industries, including the fashion, furniture, footwear, and automotive sectors, is anticipated to expand the market. Besides, Europe had a substantial share in the market due to proactive actions taken by governments in several countries in the region. By implementing these safety procedures, service providers can boost their workforce, output, and revenue.

 

Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/2342

 

Recent Developments:

  • In October 2023, PILI announced that $15.8 million had been raised in Series A investment to expedite its industrialization and produce the first tons of high-performance bio-based indigo. It was Bpifrance’s Ecotechnologies 2 fund that pushed for this funding. Elaia Partners and Famille C Participations were among the other investors.
  • In January 2024, Clariant, a German specialty chemical company emphasizing sustainability, announced that it would terminate the production of sun liquid bioethanol in Podari, Romania, and reduce related activities within its Biofuels & Derivatives business line.

Segmentation of Bio-based Pigments and Dyes Market-

Bio-based Pigments and Dyes Market- By Production

  • Microorganisms
    • Algae
    • Fungi/Fungus
    • Bacteria
  • Plant origin material

Bio-based Pigments and Dyes Market- By Application

  • Textiles
  • Pharmaceuticals
  • Cosmetics
  • Pens & Inks
  • Bio plastic
  • Food & Beverage

Bio-based Pigments and Dyes Market- By Region

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

 

For More Customization @https://www.insightaceanalytic.com/customisation/2342

Media Contact
Company Name: InsightAce Analytic Pvt. Ltd
Contact Person: Diana D’Souza
Email: Send Email
Country: United States
Website: https://www.insightaceanalytic.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Bio-based Pigments and Dyes Market 2024-2031 Exclusive Study Report By Leading Research Firm

Automated drug kiosk Market Future Scope and Latest Trends Analysis Report

“Automated drug kiosk Market”
Automated drug kiosk Market is valued at US$ 9.4 Bn in 2023, and it is expected to reach US$ 24.6 Bn by 2031, with a CAGR of 12.9% during the forecast period of 2024-2031.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Automated drug kiosk Market – (By Product Type (System, Services), By Drug Type (Prescription Medication Dispensing Kiosks, Over-the-Counter (OTC), Others (wellness products)), By End-User (Retail Pharmacies, Hospitals & Clinics, Others (workplaces, ambulatory care, etc.))), Trends, Industry Competition Analysis, Revenue and Forecast To 2031.”

According to the latest research by InsightAce Analytic, the Global Automated drug kiosk Market is valued at US$ 9.4 Bn in 2023, and it is expected to reach US$ 24.6 Bn by 2031, with a CAGR of 12.9% during the forecast period of 2024-2031.

 

Automated drug kiosks offer convenience and efficiency in dispensing medications, reducing wait times and enhancing accessibility for consumers. The market growth is propelled by technological advancements in healthcare services, rising demand for self-service options, and increasing emphasis on minimizing medication errors. The automated drug kiosk market is witnessing significant growth due to the adoption of technologies in healthcare systems globally. These kiosks provide a streamlined approach to medication dispensing, ensuring accuracy and convenience for patients. Moreover, the integration of electronic health records (EHR) with automated kiosks enhances patient safety and medication management. The growing geriatric population and the need for efficient medication management solutions also drive the market. The surge in the adoption of technology-driven drug dispensing stands out as a pivotal catalyst propelling the automated drug kiosk market forward. In regions of developing countries where the availability of pharmacies is insufficient, particularly in isolated areas, this scarcity is expected to drive the expansion of the market in the coming years. Moreover, enhancements in healthcare infrastructure, along with strategic partnerships forged with insurance companies, are poised to contribute significantly to the augmentation of market size throughout the forecast period.

 

Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/2404

 

List of Prominent Players in the Automated drug kiosk Market:

 

  • MedAvail Technoogies Inc
  • MedfriendRx
  • Stericycle Inc
  • ScriptPro LLC
  • Howell LLC
  • Smart RX Systems
  • PickPoint.
  • MC HealthGrid Pvt Ltd.
  • Asteres Inc.
  • Distributed Delivery Networks Corp.
  • TES America LLC
  • Amerisource Bergen Corporation
  • Accu Chart Plus Healthcare Systems, Inc.
  • Omnicell, Inc.
  • Other Market Players

 

 

Market Dynamics:

Drivers- 

 

The uptake of automated drug kiosks is propelled by various factors, including the imperative to minimize medication errors, boost patient adherence, and optimize operational efficiency within healthcare environments. Moreover, the escalating prevalence of chronic illnesses and the mounting strain on healthcare infrastructure contribute significantly to market advancement. Furthermore, the incorporation of artificial intelligence (AI) technology and machine learning algorithms into automated kiosks is poised to transform medication management procedures, thereby fostering market growth.

 

Challenges:

The automated drug kiosk market faces challenges related to regulatory compliance, data security concerns, and the initial high costs of installation and maintenance. Moreover, resistance to technology adoption among healthcare providers and limited accessibility in rural areas pose hurdles to market growth. Automated drug kiosks are subject to stringent regulations governing the dispensing and distribution of pharmaceuticals. Ensuring compliance with regulatory standards, such as licensing requirements, patient verification protocols, and medication safety regulations, can pose challenges for kiosk operators, hindering market growth.

 

Regional Trends:

The North American automated drug kiosks market is expected to register a major market share owing to the rising presence of advanced healthcare infrastructure, favourable government initiatives, and investments in healthcare technology. Asia Pacific follows suit, driven by stringent regulations promoting patient safety and the adoption of innovative healthcare solutions.

 

Curious About This Latest Version Of The Report? Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/2404

 

Recent Developments:

 

  • In March 2021, ravkoo™ and medifriendRx formed a collaboration to place prescription-dispensing kiosks in medical offices in Florida. ravkoo™ is a digital SaaS platform for prescriptions. This action allowed healthcare providers and medical professionals to both draft and dispense patient prescriptions within their own offices. ravkoo™ stored particular pharmaceuticals in prescription dispensing kiosks that were suitable for the medical speciality of each individual physician. 

 

  • In June 2022, Asteres reported a total of 4 million prescription pickups in 33 states across the United States and Europe. Asteres created ScriptCenter kiosks and lockers to provide a secure and safe method for retrieving prescriptions and healthcare goods. Asteres has provided services to various sectors, including retail, military sites, VA institutions, employer groups, and hospitals such as Mayo Clinic, Baylor Scott & White, Johns Hopkins, Cleveland Clinic, and Vanderbilt.

 

 

Segmentation of Automated Drug Kiosk Market-

 

By Product Type-

  • System
  • Services

By Drug Type

  • Prescription Medication Dispensing Kiosks
  • Over-the-Counter (OTC)
  • Others (wellness products)

By End-User-

  • Retail Pharmacies
  • Hospitals & Clinics
  • Others (workplaces, ambulatory care, etc.)

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

 

For More Customization @  https://www.insightaceanalytic.com/customisation/2404

Media Contact
Company Name: InsightAce Analytic Pvt. Ltd
Contact Person: Diana D’Souza
Email: Send Email
Country: United States
Website: https://www.insightaceanalytic.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Automated drug kiosk Market Future Scope and Latest Trends Analysis Report

AI and Semiconductor – a Server GPU Market Reviews Analysis Report 2024

“AI and Semiconductor – a Server GPU Market”
AI and Semiconductor – a Server GPU Market is estimated to reach over USD 134.9 Bn by 2031, exhibiting a CAGR of 30.2% during the forecast period.

AI and Semiconductor – a Server GPU Market is estimated to reach over USD 134.9 Bn by 2031, exhibiting a CAGR of 30.2% during the forecast period. 

 

Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/2412

 

AI and semiconductor – a server GPU market about the graphics processing units implemented in servers for AI purposes. As a result of their exceptional efficiency in parallel processing, GPUs are perfect for artificial intelligence and machine learning applications that demand the simultaneous handling of massive volumes of data. Rising demand for AI capabilities across sectors has fueled breakthroughs in semiconductor technology, which has led to a substantial market expansion. These advancements are meeting the demands of AI-driven applications and services. The rising need for AI and semiconductor–server GPUs is propelled by the expansion of edge computing, which moves data processing closer to its point of generation instead of depending only on shared cloud servers. The growing use of virtualization in corporate and data center settings and the phenomenal growth of AI and machine learning applications are other key factors propelling the GPU server market. However, the graphics processing unit (GPU) hardware is expensive, which can prevent startups and small businesses with smaller resources from investing in it. Because of this price, advancements in artificial intelligence semiconductors – a server GPU market- have slowed considerably.

 

List of Prominent Players in the AI and Semiconductor – a Server GPU Market:

  • Nvidia Corporation
  • Advanced Micro
  • Intel Corporation
  • Qualcomm
  • Imagination
  • ASUSTeK Computer
  • INSPUR Co., Ltd.
  • Huawei Technologies
  • GIGA-BYTE
  • Penguin Computing
  • Advantech Co., Ltd.
  • Dell Inc
  • Fujitsu
  • Exxact Corporation

 

Market Dynamics:

Drivers-

The growing demand for AI and semiconductors, a server GPU market, is fueled by the increased use of AI in a variety of industries. Due to their parallel processing capabilities, server GPUs are well-suited to deliver the strong computational capacity required for AI systems, given their complexity and volume of data processed. The need for data-driven decision-making in enterprises and services is further fueled by the growth of data centers and the wider adoption of cloud computing. Furthermore, the widespread adoption of IoT devices and the development of technologies such as smart cities and driverless cars intensify the demand for sophisticated GPUs to facilitate AI processing and algorithms and the growing demand for AI and semiconductors – a server GPU market in the coming years.

 

Challenges:

One main challenge in the AI and semiconductor – a server GPU business is the exorbitant cost of high-end GPU systems. Smaller businesses and startups may find these expenses prohibitive, which hinders the widespread use and advancement of AI applications that rely on high-performance computers. Another obstacle to deployment is the technological complexity and specialized knowledge required to design and integrate GPU-based solutions and stay competitive, facing additional financial and operational challenges due to the constant need to update and upgrade systems brought about by technology improvements. This also slows down the AI and semiconductor – a server GPU market expansion.

 

Regional Trends:

The North American AI and semiconductor – a server GPU market is anticipated to register a major market share in revenue. It is projected to grow at a high CAGR soon because the region has a long-standing technological landscape and rising innovative emphasis. Substantial investments in AI technology and robust infrastructure also expand the market. Besides, Europe had a substantial share in the market due to strict environmental restrictions pushing for the use of cutting-edge solutions. The region’s strong market position is also aided by its well-established industrial and automotive sectors, and the ever-expanding GPU market is fueling market expansion in the European region.

 

Curious About This Latest Version Of The Report? Enquiry Before Buying: https://www.insightaceanalytic.com/report/ai-and-semiconductor—a-server-gpu-market/2412

 

 

Recent Developments:

  • In February 2024, ServiceNow, the industry-leading digital workflow provider, and NVIDIA, the market leader in artificial intelligence solutions for telecommunications companies, announced a new relationship that will see the development of generative AI solutions tailored to the needs of telecommunications companies to improve customer service.
  • In February 2024, Qualcomm Technologies unveiled its seventh-generation 5G modem-to-antenna solution, the Snapdragon® X80 5G Modem-RF System, demonstrating its commitment to innovation. Snapdragon X80 achieves several world firsts with its integrated 5G AI Processor and 5G-Advanced architecture. These include the first 5G modem with fully integrated NB-NTN satellite communications support, a 6-antenna smartphone architecture, 6X carrier aggregation, and an extension of the mmWave range for fixed wireless access customer premise equipment (CPE) based on artificial intelligence.

Segmentation of AI and Semiconductor – a Server GPU Market-

By Application-

  • Cloud Computing
  • HPC Application

By Product-

  • Single GPU
  • Dual to Quad GPU
  • High-Density GPU

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

 

 For More Customization @ https://www.insightaceanalytic.com/customisation/2412

Media Contact
Company Name: InsightAce Analytic Pvt. Ltd
Contact Person: Diana D’Souza
Email: Send Email
Country: United States
Website: https://www.insightaceanalytic.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: AI and Semiconductor – a Server GPU Market Reviews Analysis Report 2024

Traditional Medicine Market Future Trends And Scope Analysis Report

“Traditional Medicine Market”
Traditional Medicine Market is valued at US$ 178.46 Bn in 2023, and it is expected to reach US$ 333.26 Bn by 2031, with a CAGR of 8.35% during the forecast period of 2024-2031.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Traditional Medicine Market – (By Product (Herbal Medicine, Ayurvedic Medicine, Unani Medicine, Alternative Medicine, Homeopathy Medicine, Others ), By Form (Capsules and Tablets, Powders and Granules, Liquid Extracts, Syrups, Creams and Ointment, Others ), By Disease Indication (Cardiac Disorders, Bone and Joint Disorders, Gynecological Disorders, Neurological and Mental Disorders, Digestive Disorders, Others), By Distribution Channel (Hospital and Retail Pharmacies, Online Pharmacies, Specialty Stores, Direct Sales), Trends, Industry Competition Analysis, Revenue and Forecast To 2031.”

According to the latest research by InsightAce Analytic, the Global Traditional Medicine Market is valued at US$ 178.46 Bn in 2023, and it is expected to reach US$ 333.26 Bn by 2031, with a CAGR of 8.35% during the forecast period of 2024-2031.

 

The use of traditional medicine often reflects the cultural beliefs of a community and is rooted in a holistic method to healing that considers the balance between mind, body, and environment. While traditional medicine practices are widely used and accepted in many parts of the world, they sometimes coexist with or complement modern medical treatments. The traditional medicine market encompasses significant growth. The global traditional medicine market has strong growth potential over the coming years. Growing acceptance of traditional medicine practices in developed regions will drive market growth. Increased consumer focus on natural and plant-based remedies is a major driver for the market. Rising healthcare costs are also expected to push consumers towards lower-cost traditional therapies. However, the need for more scientific evidence and clinical trial data makes adopting traditional medicine in Western countries challenging. More research is needed to ascertain the efficacy and safety of traditional practices. Strict regulations around traditional medicine production and sale in some parts of the world may inhibit market expansion. 

 

Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/2351

 

List of Prominent Players in the Traditional Medicine Market

  • Guizhou Yifang Pharmaceutical Co., Ltd.
  • Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd
  • Tasly Holding Group Co., Ltd.
  • Kotobuki Seiyaku Co., Ltd.
  • Herbalife Nutrition
  • Imperial Ginseng Products Ltd.
  • Hammurapi Pharma GmbH
  • Zydus Nutriva
  • Hawaii Pharma, LLC
  • VitaHealth Australia
  • Amrita Ayurvedic Pharmaceutical
  • The Himalaya Drug Company
  • Dabur
  • Kotaro Pharmaceuticals Company
  • Charak Pharma
  • Fortis Healthcare
  • Baidyanath Ayurved
  • Gaia Herbs Inc.
  • Himalaya Wellness Co.
  • Native Circle LLP
  • Nature’s Answer LLC
  • Nutraceutical International
  • Patanjali Ayurved Ltd.
  • Ricola AG
  • Schwabe Group
  • Weleda AG
  • Zandu Realty Ltd.
  • Zeinpharma Germany GMBH
  • Other Prominent Players

 

Market Dynamics:

 

Drivers- 

Increasing preference for herbal medicines is a significant driver for the Traditional Medicine Market. With more people adopting a holistic and preventive approach to health, the preference for herbal medicines over synthetic drugs is increasing globally. Consumers are now well-informed about the side effects of allopathic medications and are looking for natural remedies to treat ailments. This paradigm shift towards traditional and herbal formulations is one of the major factors positively impacting the growth of the global traditional medicine market. 

 

Government investments and rising awareness have been examined as another driver for market growth. The federal government’s increased financing to promote the adoption of these solutions has a significant impact on the market since it benefits consumers and economic stability. The increase in healthcare spending, improvements in healthcare facilities, and strong demand for enhanced care services have a beneficial impact on the social determinants of health (SDOH) market. With growing emphasis on such monitoring activities globally, it is anticipated to include the Traditional Medicine Market and significantly contribute to its growth in recent years.

 

Challenges:

The lack of scientific evidence as well as clinical trials, is significantly restraining the growth of the global traditional medicine market. While traditional medicine practices have been used for centuries across cultures, the absence of rigorous scientific validation of treatment protocols and reported health outcomes remains a major roadblock. Health regulators worldwide require transparent data from well-designed clinical trials to assess any medical intervention’s safety, efficacy, and appropriate usage before granting broader approvals or reimbursements.

Herbal products used as chemical drug alternatives have become a major restraining factor for the global traditional medicine market. With growing awareness about the side effects of allopathic drugs and consumers seeking natural therapies, many are choosing herbal remedies to treat common ailments. Various herbal formulations are being used as effective substitutes to treat diseases like diabetes, depression, anxiety, and hypertension.

 

Regional Trends:

North America has had a dominant position in the worldwide market for traditional medicine. Numerous top government and healthcare organizations in the area are addressing social issues that have an influence on public health outcomes in a groundbreaking manner. Innovative programmes aimed at addressing socioeconomic risk factors like housing, transit, education, and work have been introduced in a number of major U.S. and Canadian cities. Meanwhile, Asia Pacific is a lucrative global traditional medicine market region due to deep cultural roots and government support. Countries like China, India, Japan, and South Korea have witnessed booming demand for traditional remedies. Ayurveda has its roots in ancient Indian medicine and focuses on balancing the three doshas (life forces) – vata, pitta, and kapha – through herbs, meditation, and yoga. It treats illness by promoting good health and preventing disease rather than combating pathogens. Countries like India have also taken initiatives to promote Ayurveda globally. Traditional Latino, African, and Middle Eastern therapies also exhibit high potential but require more scientific validation and standardization. 

 

Curious About This Latest Version Of The Report? Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/2351

 

Recent Developments:

  • In Oct 2023, Himalaya Wellness Company LLC An AED 200 million Herbal Pharmaceutical Factory is being established at Dubai Industrial City, marking an expansion in the UAE. The plant will manufacture tablets, capsules, liquid orals, and ointments at Dubai Industrial City, which is a prominent manufacturing and logistics hub in the region. This development will increase the global pharmaceutical company’s presence within TECOM Group PJSC’s ecosystem in Dubai. 

 

  • In Dec 2022, Dabur India Limited introduced two innovative products – Premium Sugar-Free health restorative Ratnaprash Sugar-Free and Ayurvedic Digestive Tonic Aampachak Kadha, during the 9th World Ayurveda Congress & International AROGYA EXPO in Goa.

 

Segmentation of Traditional Medicine Market –

By Product-

  • Herbal Medicine
  • Ayurvedic Medicine
  • Unani Medicine
  • Alternative Medicine
  • Homeopathy Medicine
  • Others (Siddha Medicine, Massage Therapy, and Others)

By Disease Indication-

  • Cardiac Disorders
  • Bone and Joint Disorders
  • Gynecological Disorders
  • Neurological and Mental Disorders
  • Digestive Disorders
  • Others (Respiratory, Skin, Vision, Dental, etc.)

By Distribution Channel-

  • Hospital and Retail Pharmacies
  • Online Pharmacies
  • Specialty Stores
  • Direct Sales

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

For More Customization @ https://www.insightaceanalytic.com/customisation/2351

Media Contact
Company Name: InsightAce Analytic Pvt. Ltd
Contact Person: Diana D’Souza
Email: Send Email
Country: United States
Website: https://www.insightaceanalytic.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Traditional Medicine Market Future Trends And Scope Analysis Report

Material Informatics Market Report on the Untapped Growth Opportunities in the Industry

“Material Informatics Market”
Material Informatics Market is valued at US$ 125.1 Mn in 2023, and it is expected to reach US$ 425.9 Mn by 2031, with a CAGR of 16.6% during the forecast period of 2024-2031.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Material Informatics Market – (By Application (Chemical and Pharmaceuticals, Material Science, Manufacturing, Food Science, Energy, Others), By Material Type (Elements, Chemicals, Others), By Technique (Digital Annealer, Deep Tensor, Statistical Analysis, Genetic Algorithm)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031.”

According to the latest research by InsightAce Analytic, the Global Material Informatics Market is valued at US$ 125.1 Mn in 2023, and it is expected to reach US$ 425.9 Mn by 2031, with a CAGR of 16.6% during the forecast period of 2024-2031.

 

Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/2305

 

Material informatics is the application of materials science, computer science, and data science to discover and develop novel materials. It helps researchers to analyze and forecast material properties and behaviours by leveraging computer methodologies, machine learning algorithms, and data analytics. Material informatics discovers trends in massive databases of materials data, identifies novel materials, and optimizes existing ones for specific uses. Data mining has transformed the material science field and will create new and exciting opportunities in the near future. Furthermore, continuous advancements in novel data mining concepts for various forms of materials data, as well as the proliferation of material property databases, are predicted to continue to impact material design.

 

List of Prominent Players in the Material Informatics Market:

  • Exabyte.io
  • Alpine Electronics Inc.
  • Phaseshift Technologies
  • Nutonian Inc.
  • Schrodinger
  • Citrine Informatics
  • Materials Zone Ltd.
  • BASF
  • Kebotix
  • AI Materia
  • Tilde Materials Informatics   
  • Noble.AI  
  • Nutonian Inc.   
  • MAT3RA   
  • MaterialsDesign   
  • Hitachi High-Tech   
  • Dassault Systems 
  • Alloyed
  • Exponential Technologies (Xt)
  • Innophore
  • Intellegens    
  • Others

 

Market Dynamics:

 

Drivers- 

A number of factors are driving the Material Informatics (MI) market, emphasizing the importance and promise of this burgeoning subject. The need for quicker and cost-effective materials research and development is one of the primary reasons driving the growth of the overall material informatics market. Traditional approaches to identifying and creating novel materials can be time-consuming and costly. Material informatics solves this issue by allowing researchers to analyze large datasets more efficiently, simulate material properties, and discover potential candidates. As the demand for new materials grows across industries, the material informatics market is likely to expand steadily in the coming years.

 

Challenges:

Polymer materials have unique properties in material informatics that make building cohesive databases more difficult compared to other materials such as metals, ceramics, or biomaterials. These polymer materials are extremely complicated, and the computational approach of naming materials made of complex macromolecules has become problematic due to the wide variety of polymer shapes. Aside from chemical composition, the polymer category comprises copolymerization, polymer blending, linear versus branched polymer, and polymer mixing, which is also utilized for material informatics, resulting in greater complexity during product execution. Polymer materials’ characteristics are rarely mono-disperse and are made up of macromolecular chains that vary in length. A polymer sample’s discrepancy can considerably impact the measured property of the polymer.

 

Regional Trends:

The North America Material Informatics Market is expected to register a major market revenue share and is projected to grow at a high CAGR in the near future due to increased investments in the field of material science and analysis, as well as increased research and development efforts in many sectors such as electronics, chemicals, and many others. Furthermore, as a technology leader, the region is at the forefront of adopting modern technologies such as AI, Machine Learning, big data, and data analytics. Integrating AI, machine learning, and data science has created a new paradigm for future market prospects.

 

Curious About This Latest Version Of The Report? Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/2305

 

Recent Developments:

  • In Apr 2022, LyondellBasell established a long-term partnership with Citrine Informatics to make use of the Citrine Platform for Materials Informatics and product development led by artificial intelligence.

 

Segmentation of Material Informatics Market-

By Application-

  • Chemical and Pharmaceuticals
  • Material Science
  • Manufacturing
  • Food Science
  • Energy
  • Others

By Material Type-

  • Elements
  • Chemicals
  • Others

By Technique-

  • Digital Annealer
  • Deep Tensor
  • Statistical Analysis
  • Genetic Algorithm

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

 

For More Customization @ https://www.insightaceanalytic.com/customisation/2305

Media Contact
Company Name: InsightAce Analytic Pvt. Ltd
Contact Person: Diana D’Souza
Email: Send Email
Country: United States
Website: https://www.insightaceanalytic.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Material Informatics Market Report on the Untapped Growth Opportunities in the Industry

Bodybuilding Supplements Market Exclusive Report with Detailed Study Analysis

“Bodybuilding Supplements Market”
Bodybuilding Supplements Market is valued at US$ 24.5 Bn in 2023, and it is expected to reach US$ 46.5 Bn by 2031, with a CAGR of 8.57% during the forecast period of 2024-2031.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Bodybuilding Supplements Market – (By Product Type (Protein Supplements, Pre-Workout Supplements, Creatine, BCAA Supplements, Fat Burners, Multivitamins, Others), By Source Type (Animal-based, Plant-based), By Age Group (Millennials, Generation Z, Baby Boomers), By Form (Powder, Capsules, Tablets, Liquids, Softgels, Others), By Distribution Channel (Supermarkets & Hypermarkets, E-commerce and Online Stores, Drug stores and Pharmacies, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031.”

According to the latest research by InsightAce Analytic, the Global Bodybuilding Supplements Market is valued at US$ 24.5 Bn in 2023, and it is expected to reach US$ 46.5 Bn by 2031, with a CAGR of 8.57% during the forecast period of 2024-2031.

 

Bodybuilding supplements are dietary products used by individuals engaged in bodybuilding, athletics, and fitness to facilitate muscle gain, enhance performance, or aid in recovery. These supplements come in various forms, including powders, pills, and shakes, and are designed to complement an individual’s diet and workout regimen. The most popular protein sources include branched-chain amino acids (BCAA), arginine, glutamine, essential fatty acids, creatine, whey protein, HMB, ZMA, and high-protein beverages. The growing interest in fitness and health consciousness is driving the steady rise of the global bodybuilding supplement industry. Additionally, bodybuilders and fitness fanatics have been putting more and more emphasis on nutrition and general well-being in recent years. The idea that one may effectively achieve daily macronutrient needs by food alone is becoming more and more focused on the consumption of vitamins, proteins, and meal replacement items. The everyday nutrition and health solutions that have replaced conventional training supplements are having a significant influence on the worldwide bodybuilding supplement business.

 

Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/2346

 

List of Prominent Players in the Bodybuilding Supplements Market

  • Glanbia plc
  • Abbott
  • GSK
  • Amway
  • Nestlé S.A.
  • MusclePharm.
  • BA Sports Nutrition
  • CSN
  • AMCO Proteins
  • Dymatize Enterprises LLC.
  • CytoSport Inc.
  • RSP Nutrition
  • GELITA AG
  • Hoogwegt.
  • Mondelez International group.
  • QuestNutrition & WorldPantry.com LLC.
  • The Bountiful Company
  • MTS Nutrition
  • Optimum Nutrition
  • Core Nutritionals
  • Ambrosia Nutraceuticals
  • UMP Healthcare Holdings Limited
  • Beverly International Nutrition
  • Blackstone Labs
  • Kaged Muscle
  • NutraBio Labs
  • GNC
  • MTS Nutrition
  • MuscleTech
  • Dymatize
  • Other Prominent Players

 

Market Dynamics:

 

Drivers- 

The rising awareness about health and fitness drives the growth of the bodybuilding supplements market. With increasing health consciousness, consumers opt for bodybuilding supplements to maintain fitness and build muscle mass. Protein supplements are the most popular among gym-goers and athletes for muscle recovery and gains. Furthermore, the easy availability of these supplements through online retail channels and the growing millennial population are also fueling the market growth. Easy accessibility through online and brick-and-mortar retail outlets has dramatically boosted the global bodybuilding supplements market in recent years. Bodybuilders and fitness enthusiasts can purchase virtually any legal supplement from various online stores with a click of a button. The popularity of bodybuilding as a sport and fitness activity has grown significantly over the past decade. More and more people focus on health, fitness, and a toned physique. They are joining gyms and following rigorous workout routines. However, achieving the desired body type through exercise and diet alone can be challenging and time-consuming. This is creating a huge demand for the bodybuilding supplements market.

 

 Challenges:

The high price of supplements due to high manufacturing costs is significantly restraining the growth of the global bodybuilding supplements market. High production costs are associated with supplements products in the global bodybuilding supplements market. Moreover, Stringent regulations governing the pharmaceutical and nutraceutical industries require extensive quality control procedures, including the need for cleanroom environments and regular audits. Adhering to these standards increases overall production costs. The body supplements Market faces challenges of regulatory scrutiny, ensuring product safety and efficacy, maintaining consumer trust amidst controversies, combating misinformation, and addressing concerns regarding long-term health impacts. Competition intensifies as trends shift towards natural and sustainable options, requiring constant innovation and transparent communication to meet evolving consumer demands.

 

Regional Trends:

North America is anticipated to be the largest Market for bodybuilding supplements throughout the projected period. For bodybuilding supplements, North America has emerged as the leading regional Market. This is because of the robust healthcare systems and spending in the United States and other nations in the area, as well as the large number of prominent enterprises that deal with nutrition, nutraceuticals, and dietary supplements. These businesses have been making significant investments in R&D to create novel products and formulations that cater to a variety of age groups and use cases. As a result, the area leads the world in patent applications and benefits from early product acceptance.

 

Curious About This Latest Version Of The Report? Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/2346

 

Recent Developments:

 

  • In Jan 2024, Abbott Laboratories introduced a new protein shake designed to assist individuals in weight loss and muscle mass maintenance. The healthcare company revealed that the protein shake is the initial product to be introduced under its new brand, Protality. Abbott’s decision was a strategic move to take advantage of the increased demand for novel weight-loss medications belonging to the GLP-1 class.

 

  • In March 2022, MusclePharm Corporation, a global provider of leading sports nutrition and lifestyle branded nutritional supplements, announced the launch of a ready-to-drink protein category with the product ‘whey protein drink’ line in the summer of 2022, which contains over 20g of protein, be sugar-free and will be available in multiple flavours.

 

Segmentation of  Bodybuilding Supplements Market –

By Product Type:-

  • Protein Supplements
  • Pre-Workout Supplements
  • Creatine
  • BCAA Supplements
  • Fat Burners
  • Multivitamins
  • Others

By Source Type

  • Animal-based
  • Plant-based

By Age Group

  • Millennials
  • Generation Z
  • Baby Boomers

By Form

  • Powder
  • Capsules
  • Tablets
  • Liquids
  • Softgels
  • Others

By Distribution Channel

  • Supermarkets & Hypermarkets
  • E-commerce and Online Stores
  • Drug stores and Pharmacies
  • Others

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

For More Customization @ https://www.insightaceanalytic.com/customisation/2346

Media Contact
Company Name: InsightAce Analytic Pvt. Ltd
Contact Person: Diana D’Souza
Email: Send Email
Country: United States
Website: https://www.insightaceanalytic.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Bodybuilding Supplements Market Exclusive Report with Detailed Study Analysis

Workout Supplements Market Report on Size, Share, Scope and Forecast 2024-2031 By Top Research Firm

“Workout Supplements Market”
Workout Supplements Market is valued at US$ 18.17 Bn in 2023, and it is expected to reach US$ 35.55 Bn by 2031, with a CAGR of 8.95% during the forecast period of 2024-2031.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Workout Supplements Market – (By Product Type (Powder, Capsule/ Tablet, Drinks), By Distribution Channel (Supermarkets & Hypermarkets, E-commerce and Online Stores, Drug stores and Pharmacies, Other Offline stores)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031.”

According to the latest research by InsightAce Analytic, the Global Workout Supplements Market is valued at US$ 18.17 Bn in 2023, and it is expected to reach US$ 35.55 Bn by 2031, with a CAGR of 8.95% during the forecast period of 2024-2031.

 

The increasing emphasis on health and fitness across demographics drove the demand for workout supplements. Consumers were becoming more conscious of the need for proper nutrition to support their fitness regimes, leading to a higher uptake of supplements like protein powders, pre-workout formulas, and amino acids. Furthermore, the growing popularity of fitness activities, gym memberships, and sports participation globally contributed to the market’s expansion. As more individuals engaged in workouts, exercises, and athletic activities, the demand for supplements to enhance performance, support muscle recovery, and achieve fitness goals increased.

 

Moreover, the influence of social media, fitness influencers, and celebrity endorsements played a significant role in driving consumer awareness and interest in workout supplements. These platforms acted as powerful marketing channels, reaching a wide audience and influencing purchasing decisions.

 

Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/2350

 

List of Prominent Players in the Workout Supplements Market

  • Abbott
  • BSN
  • Finaflex
  • EFX Sports
  • Nutrex Research
  • SynTech Nutrition
  • BPI Sports LLC
  • Nutrabolt
  • JNX Sports
  • SAN
  • eFlow Nutrition LLC.
  • Other Prominent Players

 

Market Dynamics:

 

Drivers- 

The rising awareness about health and fitness drives the growth of the Workout Supplements Market. With increasing health consciousness, consumers opt for bodybuilding supplements to maintain fitness and build muscle mass. Protein supplements are the most popular among gym-goers and athletes for muscle recovery and gains. Furthermore, the easy availability of these supplements through online retail channels and the growing millennial population are also fueling the market growth. Easy accessibility through online and brick-and-mortar retail outlets has dramatically boosted the global Workout Supplements Market in recent years. Bodybuilders and fitness enthusiasts can now purchase virtually any legal supplement from various online stores with a click of a button. The popularity of bodybuilding as a sport and fitness activity has grown significantly over the past decade. More and more people focus on health, fitness, and a toned physique. They are joining gyms and following rigorous workout routines. However, achieving the desired body type through exercise and diet alone can be challenging and time-consuming. Increasing the prevalence of obesity and lifestyle diseases is another major factor positively impacting this industry. All these drivers are creating a huge demand for the bodybuilding supplement market.

 

Challenges:

High pricing of Branded Workout Supplements due to high manufacturing costs is significantly restraining the growth of the global Workout Supplements Market. The issue of high production costs associated with supplements products in the global Workout Supplements Market. Concerns regarding product safety and side effects pose a major restraint for the global workout supplement market. Consumers are increasingly skeptical about the potential health risks associated with the extended usage of certain supplements. This is because some supplements must be conclusively proven safe for prolonged intake. The body supplements market faces challenges of regulatory scrutiny, ensuring product safety and efficacy, maintaining consumer trust amidst controversies, combating misinformation, and addressing concerns regarding long-term health impacts. Competition intensifies as trends shift towards natural and sustainable options, requiring constant innovation and transparent communication to meet evolving consumer demands.

 

Regional Trends:

For workout supplements, North America has emerged as the leading regional market. This is because large nutrition, dietary supplement, and nutraceutical firms are widely present in the area, and nations like the United States have robust healthcare infrastructures and expenditures. As a result, the area has a leading percentage of patent applications and benefits from the early adoption of innovative goods. Although growth is slower in mature markets than in other countries due to legislation, population demographics, and market maturity, ongoing innovation guarantees that end consumers of pharmaceuticals and nutraceuticals will always have a need.

 

Curious About This Latest Version Of The Report? Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/2350

 

Recent Developments:

 

  • In September 2022, Abbott introduced a novel formulation of Ensure with HMB, which is designed to assist the ageing of Indians. The new Ensure is a scientifically supported dietary supplement containing 32 essential nutrients, including vitamin D, high-quality protein, and calcium, to support and enhance bone and muscle strength. 

 

  • In July 2023, WWE, a professional wrestling organization, and Nutrabolt, the proprietor of the C4 brand and a rapidly expanding, international active health and wellness corporation, jointly declared the commencement of their inaugural co-branded product collaboration: C4 Ultimate Pre-Workout Powder and C4 Ultimate Energy Drink featuring flavours inspired by WWE. This development marks an extension of their multi-year partnership.

 

Segmentation of  Workout Supplements Market –

By Product Type:-

  • Powder
  • Capsule/ Tablet
  • Drinks
  • Other Types

By Distribution Channel:-

  • Supermarkets & Hypermarkets
  • E-commerce and Online Stores
  • Drug stores and Pharmacies
  • Other Offline stores

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

For More Customization @ https://www.insightaceanalytic.com/customisation/2350

Media Contact
Company Name: InsightAce Analytic Pvt. Ltd
Contact Person: Diana D’Souza
Email: Send Email
Country: United States
Website: https://www.insightaceanalytic.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Workout Supplements Market Report on Size, Share, Scope and Forecast 2024-2031 By Top Research Firm